Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12668584rdf:typepubmed:Citationlld:pubmed
pubmed-article:12668584lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:12668584lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12668584lifeskim:mentionsumls-concept:C0079281lld:lifeskim
pubmed-article:12668584lifeskim:mentionsumls-concept:C0225828lld:lifeskim
pubmed-article:12668584lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12668584lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:12668584pubmed:issue5lld:pubmed
pubmed-article:12668584pubmed:dateCreated2003-5-5lld:pubmed
pubmed-article:12668584pubmed:abstractTextApoptosis of cardiac myocytes is thought to be a feature of many pathological disorders, including congestive heart failure (CHF) and ischemic heart disease (IHD). Because recent investigations indicate that endothelin-1 (ET-1) plays an important role in CHF and IHD, we investigated the effect of ET-1 on cardiomyocyte apoptosis. The presence of apoptosis in rat cardiomyocytes (H9c2 and neonatal) was evaluated by morphological criteria, electrophoresis of DNA fragments, 4',6'-diamidine-2'-phenylindole staining, and TUNEL analysis. ET-1, but not angiotensin II, prevented apoptosis induced by serum deprivation via ETA receptors in a dose-dependent manner (1 to 100 nmol/L). ET-1 also prevented cytochrome c release from mitochondria to the cytosol. The use of specific pharmacological inhibitors demonstrated that the antiapoptotic effect of ET-1 was mediated through a tyrosine kinase pathway (genistein and AG490) but not through protein kinase C (PKC; calphostin C), mitogen-activated protein kinases (PD98059 and SB203580), or PKA (KT5270) pathways. Adenovirus-mediated gene transfer of kinase-inactive (KI) c-Src reversed the antiapoptotic effect of ET-1. We further investigated whether Bcl-xL, an antiapoptotic molecule, would be upregulated by using a luciferase-based reporter system. ET-1 upregulated Bcl-xL, and this upregulation was inhibited by genistein or AG490 but not by calphostin C. The experiments with KI mutants for various tyrosine kinases revealed that c-Src and Pyk2 (but not JAK1, Jak2, Syk, and Tec) are involved in ET-1-induced upregulation of Bcl-xL expression. These findings suggest that ET-1 prevents apoptosis in cardiac myocytes through the ETA receptor and the subsequent c-Src/Bcl-xL-dependent pathway.lld:pubmed
pubmed-article:12668584pubmed:languageenglld:pubmed
pubmed-article:12668584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:citationSubsetIMlld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12668584pubmed:statusMEDLINElld:pubmed
pubmed-article:12668584pubmed:monthMaylld:pubmed
pubmed-article:12668584pubmed:issn1524-4563lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:OzawaKeiyaKlld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:BerkBradford...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:TakahashiMasa...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:OgataYukiyoYlld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:TakeuchiKoich...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:KobayashiEiji...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:IkedaUichiUlld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:ShimadaKazuyu...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:OokawaraShige...lld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:OkadaTakashiTlld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:ManoHiroyukiHlld:pubmed
pubmed-article:12668584pubmed:authorpubmed-author:UenoShuichiSlld:pubmed
pubmed-article:12668584pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12668584pubmed:volume41lld:pubmed
pubmed-article:12668584pubmed:ownerNLMlld:pubmed
pubmed-article:12668584pubmed:authorsCompleteYlld:pubmed
pubmed-article:12668584pubmed:pagination1156-63lld:pubmed
pubmed-article:12668584pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:meshHeadingpubmed-meshheading:12668584...lld:pubmed
pubmed-article:12668584pubmed:year2003lld:pubmed
pubmed-article:12668584pubmed:articleTitleAntiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro.lld:pubmed
pubmed-article:12668584pubmed:affiliationDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical School, Tochigi, Japan.lld:pubmed
pubmed-article:12668584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12668584pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:50646entrezgene:pubmedpubmed-article:12668584lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12668584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12668584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12668584lld:pubmed